BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22184106)

  • 21. Granular expression of prolyl-peptidyl isomerase PIN1 is a constant and specific feature of Alzheimer's disease pathology and is independent of tau, Aβ and TDP-43 pathology.
    Dakson A; Yokota O; Esiri M; Bigio EH; Horan M; Pendleton N; Richardson A; Neary D; Snowden JS; Robinson A; Davidson YS; Mann DM
    Acta Neuropathol; 2011 May; 121(5):635-49. PubMed ID: 21243369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pin1 cysteine-113 oxidation inhibits its catalytic activity and cellular function in Alzheimer's disease.
    Chen CH; Li W; Sultana R; You MH; Kondo A; Shahpasand K; Kim BM; Luo ML; Nechama M; Lin YM; Yao Y; Lee TH; Zhou XZ; Swomley AM; Butterfield DA; Zhang Y; Lu KP
    Neurobiol Dis; 2015 Apr; 76():13-23. PubMed ID: 25576397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of the prolyl isomerase Pin1 in protecting against age-dependent neurodegeneration.
    Liou YC; Sun A; Ryo A; Zhou XZ; Yu ZX; Huang HK; Uchida T; Bronson R; Bing G; Li X; Hunter T; Lu KP
    Nature; 2003 Jul; 424(6948):556-61. PubMed ID: 12891359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pin1 in Alzheimer's disease: multiple substrates, one regulatory mechanism?
    Balastik M; Lim J; Pastorino L; Lu KP
    Biochim Biophys Acta; 2007 Apr; 1772(4):422-9. PubMed ID: 17317113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrochemical investigations of Tau protein phosphorylations and interactions with Pin1.
    Martić S; Beheshti S; Kraatz HB; Litchfield DW
    Chem Biodivers; 2012 Sep; 9(9):1693-702. PubMed ID: 22976962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pin1: a new outlook in Alzheimer's disease.
    Lonati E; Masserini M; Bulbarelli A
    Curr Alzheimer Res; 2011 Sep; 8(6):615-22. PubMed ID: 21605045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fuzhisan ameliorates Aβ production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Zhang ZX; Zhao RP; Wang DS; Wang AN
    Exp Gerontol; 2016 Nov; 84():88-95. PubMed ID: 27612601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. γ-Aminobutyric acid type A (GABAA) receptor activation modulates tau phosphorylation.
    Nykänen NP; Kysenius K; Sakha P; Tammela P; Huttunen HJ
    J Biol Chem; 2012 Feb; 287(9):6743-52. PubMed ID: 22235112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease.
    Ueberham U; Rohn S; Ueberham E; Wodischeck S; Hilbrich I; Holzer M; Brückner MK; Gruschka H; Arendt T
    Neuropathol Appl Neurobiol; 2014 Dec; 40(7):815-32. PubMed ID: 24964035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.
    Kirouac L; Rajic AJ; Cribbs DH; Padmanabhan J
    eNeuro; 2017; 4(2):. PubMed ID: 28374012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utilizing the peptidyl-prolyl cis-trans isomerase pin1 as a probe of its phosphorylated target proteins. Examples of binding to nuclear proteins in a human kidney cell line and to tau in Alzheimer's diseased brain.
    Thorpe JR; Morley SJ; Rulten SL
    J Histochem Cytochem; 2001 Jan; 49(1):97-108. PubMed ID: 11118482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid-β pathology is attenuated by tauroursodeoxycholic acid treatment in APP/PS1 mice after disease onset.
    Dionísio PA; Amaral JD; Ribeiro MF; Lo AC; D'Hooge R; Rodrigues CM
    Neurobiol Aging; 2015 Jan; 36(1):228-40. PubMed ID: 25443293
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of GSK3β-mediated BACE1 expression reduces Alzheimer-associated phenotypes.
    Ly PT; Wu Y; Zou H; Wang R; Zhou W; Kinoshita A; Zhang M; Yang Y; Cai F; Woodgett J; Song W
    J Clin Invest; 2013 Jan; 123(1):224-35. PubMed ID: 23202730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease.
    Takahashi K; Uchida C; Shin RW; Shimazaki K; Uchida T
    Cell Mol Life Sci; 2008 Feb; 65(3):359-75. PubMed ID: 17965833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.
    Lu PJ; Wulf G; Zhou XZ; Davies P; Lu KP
    Nature; 1999 Jun; 399(6738):784-8. PubMed ID: 10391244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dishevelled regulates the metabolism of amyloid precursor protein via protein kinase C/mitogen-activated protein kinase and c-Jun terminal kinase.
    Mudher A; Chapman S; Richardson J; Asuni A; Gibb G; Pollard C; Killick R; Iqbal T; Raymond L; Varndell I; Sheppard P; Makoff A; Gower E; Soden PE; Lewis P; Murphy M; Golde TE; Rupniak HT; Anderton BH; Lovestone S
    J Neurosci; 2001 Jul; 21(14):4987-95. PubMed ID: 11438574
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pin1-dependent prolyl isomerization modulates the stress-induced phosphorylation of high molecular weight neurofilament protein.
    Rudrabhatla P; Zheng YL; Amin ND; Kesavapany S; Albers W; Pant HC
    J Biol Chem; 2008 Sep; 283(39):26737-47. PubMed ID: 18635547
    [TBL] [Abstract][Full Text] [Related]  

  • 38. β2 adrenergic receptor, protein kinase A (PKA) and c-Jun N-terminal kinase (JNK) signaling pathways mediate tau pathology in Alzheimer disease models.
    Wang D; Fu Q; Zhou Y; Xu B; Shi Q; Igwe B; Matt L; Hell JW; Wisely EV; Oddo S; Xiang YK
    J Biol Chem; 2013 Apr; 288(15):10298-307. PubMed ID: 23430246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spectroscopic studies of GSK3{beta} phosphorylation of the neuronal tau protein and its interaction with the N-terminal domain of apolipoprotein E.
    Leroy A; Landrieu I; Huvent I; Legrand D; Codeville B; Wieruszeski JM; Lippens G
    J Biol Chem; 2010 Oct; 285(43):33435-33444. PubMed ID: 20679343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pin1 contribution to Alzheimer's disease: transcriptional and epigenetic mechanisms in patients with late-onset Alzheimer's disease.
    Arosio B; Bulbarelli A; Bastias Candia S; Lonati E; Mastronardi L; Romualdi P; Candeletti S; Gussago C; Galimberti D; Scarpini E; Dell'Osso B; Altamura C; MacCarrone M; Bergamaschini L; D'Addario C; Mari D
    Neurodegener Dis; 2012; 10(1-4):207-11. PubMed ID: 22261503
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.